Stay updated on Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    The record now presents details of the completed phase IIb study of pembrolizumab and BL-8040 for metastatic pancreatic cancer, including its eligibility criteria, treatment plan, outcomes, and posted results.
    Difference
    50%
    Check dated 2026-11-07T14:24:25.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0, while the study record page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-31T15:22:17.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The record now presents details of the completed phase II study of pembrolizumab and BL-8040 for metastatic pancreatic cancer, including eligibility criteria, treatment plan, outcome measures, results links, and study documents.
    Difference
    53%
    Check dated 2026-10-24T17:14:27.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The footer’s site revision identifier changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-17T16:59:59.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer’s displayed ClinicalTrials.gov revision changed from v3.7.0 to v3.7.1; the page continues to show a 403 Forbidden error.
    Difference
    0.2%
    Check dated 2026-10-10T17:59:52.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, replacing the detailed study content with an error page. Previously visible trial information and institutional references have been removed or hidden, changing how the page functions and navigates.
    Difference
    19%
    Check dated 2026-09-19T19:12:53.000Z thumbnail image

Stay in the know with updates to Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab+BL-8040 in Metastatic Pancreatic Cancer Clinical Trial page.